![Ernest Loumaye](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ernest Loumaye
Fondatore presso OBSEVA SA
Patrimonio netto: 13 500 $ in data 30/06/2024
Posizioni attive di Ernest Loumaye
Società | Posizione | Inizio | Fine |
---|---|---|---|
OBSEVA SA | Presidente | 13/03/2023 | - |
Fondatore | 14/11/2012 | - | |
Direttore/Membro del Consiglio | 14/11/2012 | 13/03/2023 | |
Amministratore Delegato | 14/11/2012 | 01/12/2020 | |
Direttore Tecnico/Scientifico/R&S | 14/11/2012 | 22/09/2015 |
Storia della carriera di Ernest Loumaye
Precedenti posizioni note di Ernest Loumaye
Società | Posizione | Inizio | Fine |
---|---|---|---|
Ava AG
![]() Ava AG Miscellaneous Commercial ServicesCommercial Services Ava AG develops and offers a fertility band that allows for birth control. It offers a bracelet that indicates days on which it is possible to become pregnant. The company was founded by Lea von Bidder, Peter Stein, Philipp Tholen and Pascal Koenig in 2014 and is headquartered in Zurich, Switzerland. | Direttore/Membro del Consiglio | 01/09/2019 | 01/01/2021 |
Calliditas Therapeutics Suisse SA
![]() Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Presidente | 26/05/2011 | 01/01/2016 |
PregLem SA
![]() PregLem SA Pharmaceuticals: MajorHealth Technology PregLem SA manufactures and markets pharmaceutical products specializing in gynecology and women's reproductive health. Its products include ESMYA, PGL2001, and PGL1001. The company was founded in June 2006 and is headquartered in Geneva, Switzerland. | Amministratore Delegato | 01/06/2006 | 01/10/2012 |
Fondatore | 29/07/2009 | 01/10/2012 | |
IPSEN | Corporate Officer/Principal | 01/01/2003 | - |
Serono SA
![]() Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | Corporate Officer/Principal | - | - |
Formazione di Ernest Loumaye
Université Catholique de Louvain | Doctorate Degree |
Statistiche
Distribuzione geografica
Svizzera | 6 |
Belgio | 2 |
Francia | 2 |
Posizioni
Chief Executive Officer | 2 |
Founder | 2 |
Corporate Officer/Principal | 2 |
Settori
Health Technology | 6 |
Consumer Services | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
OBSEVA SA | Health Technology |
IPSEN | Health Technology |
Aziende private | 4 |
---|---|
PregLem SA
![]() PregLem SA Pharmaceuticals: MajorHealth Technology PregLem SA manufactures and markets pharmaceutical products specializing in gynecology and women's reproductive health. Its products include ESMYA, PGL2001, and PGL1001. The company was founded in June 2006 and is headquartered in Geneva, Switzerland. | Health Technology |
Serono SA
![]() Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | Health Technology |
Calliditas Therapeutics Suisse SA
![]() Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Health Technology |
Ava AG
![]() Ava AG Miscellaneous Commercial ServicesCommercial Services Ava AG develops and offers a fertility band that allows for birth control. It offers a bracelet that indicates days on which it is possible to become pregnant. The company was founded by Lea von Bidder, Peter Stein, Philipp Tholen and Pascal Koenig in 2014 and is headquartered in Zurich, Switzerland. | Commercial Services |
- Borsa valori
- Insiders
- Ernest Loumaye
- Esperienza